| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |